Wells Fargo’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Buy |
33,697
+5,142
| +18% | +$23.2K | ﹤0.01% | 4539 |
|
|
2025
Q1 | $132K | Sell |
28,555
-41,607
| -59% | -$193K | ﹤0.01% | 4502 |
|
|
2024
Q4 | $487K | Buy |
70,162
+47,952
| +216% | +$333K | ﹤0.01% | 3740 |
|
|
2024
Q3 | $118K | Buy |
22,210
+5,902
| +36% | +$31.3K | ﹤0.01% | 4531 |
|
|
2024
Q2 | $61K | Buy |
16,308
+3,089
| +23% | +$11.6K | ﹤0.01% | 4855 |
|
|
2024
Q1 | $93.2K | Buy |
13,219
+1,336
| +11% | +$9.42K | ﹤0.01% | 4560 |
|
|
2023
Q4 | $67.1K | Buy |
11,883
+2,127
| +22% | +$12K | ﹤0.01% | 4733 |
|
|
2023
Q3 | $46.7K | Sell |
9,756
-3,894
| -29% | -$18.7K | ﹤0.01% | 4865 |
|
|
2023
Q2 | $93.5K | Buy |
13,650
+8,133
| +147% | +$55.7K | ﹤0.01% | 4818 |
|
|
2023
Q1 | $43K | Buy |
+5,517
| New | +$43K | ﹤0.01% | 4950 |
|
|
2022
Q4 | – | Sell |
-80
| Closed | -$1K | – | 7215 |
|
|
2022
Q3 | $1K | Sell |
80
-173
| -68% | -$2.16K | ﹤0.01% | 6013 |
|
|
2022
Q2 | $2K | Sell |
253
-15,491
| -98% | -$122K | ﹤0.01% | 6018 |
|
|
2022
Q1 | $221K | Sell |
15,744
-36
| -0.2% | -$505 | ﹤0.01% | 4625 |
|
|
2021
Q4 | $322K | Buy |
15,780
+15,723
| +27,584% | +$321K | ﹤0.01% | 4657 |
|
|
2021
Q3 | $1K | Buy |
+57
| New | +$1K | ﹤0.01% | 6372 |
|